Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis.

Jacopo F ImbertiWern Yew DingAgnieszka KotalczykJuqian ZhangGiuseppe Boriani Gregory Yoke Hong Lip Jason A Gencher Dhiraj Gupta

Published in: Heart (British Cardiac Society) (2021)

First-line treatment with CA is superior to AAD therapy in patients with symptomatic paroxysmal AF, as it significantly reduces the recurrence of any atrial arrhythmias and symptomatic atrial arrhythmias, and healthcare resource utilisation with comparable safety profile.

Keyphrases

mesenchymal stem cells
catheter ablation
atrial fibrillation
left atrial
healthcare
left atrial appendage
oral anticoagulants
congenital heart disease
cell therapy
direct oral anticoagulants
heart failure
percutaneous coronary intervention
coronary artery disease
stem cells
left ventricular
mitral valve